Shifting the population health outcome curve in primary care

Report
Population Health Gain in
Primary Care
Dr Hilary Guite FFPH MRCGP Consultant Public Health Medicine
Public Health England [email protected]
How good is the NHS at population health gain
compared to other economically developed countries?
UK
19/33
2
Presentation title - edit in Header and Footer
The fantastic opportunity of
the NHS:
Universal access and patient
registration
UK
Fantastic opportunity of
primary care- 90% of all
NHS contacts carried
out in primary care
The session
INTRODUCTION
•
Shifting the population health outcome curve in primary care.
Dr Hilary Guite Consultant Public Health Medicine Public Health England
CASE STUDIES
•
Diabetes identification and management improving life expectancy
Dr Junaid Bajwa Conway Practice Plumstead, London
•
Hypertension management and reductions in CHD emergencies and the role of an academic network in realising
population health gains
Dr John Robson Chrisp Street health centre. Tower Hamlets London.
•
Physical activity and reducing obesity
Dr William Bird. Intelligent Health
SUMMARY
•
How general practice can work with the generally well to become optimally well and the nearly sick to become
generally well.
Ms Shakti Dookeran. Population Health Services Manager
•
4
.
Presentation title - edit in Header and Footer
The ideal prevention strategy- shifting the population health
outcome curve
Source WHO/WHF/WSO. 2011 Global atlas on CVD prevention and control
The ideal prevention strategy
Shift whole
population
mean by
reducing
population risk
factors
Early diagnosis;
management of
risk factors; BP;
raised HBA1C
etc
Identify and
actively
manage
people with
disease
Source WHO/WHF/WSO. 2011 Global atlas on CVD prevention and control
Any questions?
7
Spare slide
Rank order of effective interventions resulting in reduction in CHD
mortality 2000-2007 UK
1. (E) Fall in BP in the general population not on medication 29%:
11,160 DPP (deaths prevented or postponed)
with salt ↓
Consistent
2. (A) Lipid reduction with statin treatment 14% 5,300 DPP
3. (G) Improved management of stable CAD in the community 13%
4. (H) Improved secondary prevention post MI or revascularisation
11%
5. (I) Improved management of heart failure 9%
6. (B) Reductions in Total Cholesterol in the general population
not on statins 6%
7. (F) Hypertension medication 5%
8. (D) Changes in hospital based patient groups NSTEACS 0.8%
9. (C) Changes in hospital based patient groups – STEMI – 0.3%

similar documents